Page 1

Interim Report Q2 Webcast 20 August 2026 Innovative immunotherapies for a healthier world Nasdaq First North : EXPRS2 Expres2ion Biotech Holding AB Company reg . no . 559033-3729 expres2ion BIOTECH Hosted by HC ANDERSEN CAPITAL